Prospective trial to evaluate the prognostic value of different nutritional assessment scores in pancreatic surgery (NURIMAS Pancreas).
Published: 30th March 2017
Authors: P. Probst, S. Haller, T. Bruckner, A. Ulrich, O. Strobel, T. Hackert et al.
Preoperative nutritional status has an impact on patients' clinical outcome. For pancreatic surgery, however, it is unclear which nutritional assessment scores adequately assess malnutrition associated with postoperative outcome.
Patients scheduled for elective pancreatic surgery at the University of Heidelberg were screened for eligibility. Twelve nutritional assessment scores were calculated before operation, and patients were categorized as either at risk or not at risk for malnutrition by each score. The postoperative course was monitored prospectively by assessors blinded to the nutritional status. The primary endpoint was major complications evaluated for each score in a multivariable analysis corrected for known risk factors in pancreatic surgery.
Overall, 279 patients were analysed. A major complication occurred in 61 patients (21·9 per cent). The proportion of malnourished patients differed greatly among the scores, from 1·1 per cent (Nutritional Risk Index) to 79·6 per cent (Nutritional Risk Classification). In the multivariable analysis, only raised amylase level in drainage fluid on postoperative day 1 (odds ratio (
None of the nutritional assessment scores defined malnutrition relevant to complications after pancreatic surgery and these scores may thus be abandoned.Read more
You may also be interested in
Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death grafts.
Authors: R. van Rijn, N. Karimian, A. P. M. Matton, L. C. Burlage, A. C. Westerkamp, A. P. van den Berg et al.
Notes: Increases donor pool
Authors: F. J. Hüttner, P. Probst, P. Knebel, O. Strobel, T. Hackert, A. Ulrich et al.
Notes: No benefit
Authors: K. Sasaki, G. A. Margonis, N. Andreatos, A. Wilson, M. Weiss, C. Wolfgang et al.
Notes: Anti‐angiogenesis antibody of benefit
Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases.
Authors: A. E. Vallance, J. vanderMeulen, A. Kuryba, I. D. Botterill, J. Hill, D. G. Jayne et al.
Notes: Better survival
Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. BJS 2017; 104: 760-768.
Authors: B. C. Odisio, S. Yamashita, S. Y. Huang, S. Harmoush, S. E. Kopetz, K. Ahrar et al.
Notes: Mutant RAS poor prognostic factor
Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine‐based chemotherapy. BJS 2017; 104: 328-336.
Authors: N. T. E. Bird, M. Elmasry, R. Jones, E. Psarelli, J. Dodd, H. Malik et al.
Notes: Standardization needed to see if it's really useful
Authors: I. Tarantino, R. Warschkow, T. Hackert, B. M. Schmied, M. W. Büchler, O. Strobel et al.
Notes: Higher number, lower survival
Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model. BJS 2017; 104: 590-599.
Authors: P. B. Olthof, F. Huisman, F. G. Schaap, K. P. van Lienden, R. J. Bennink, R. F. van Golen et al.
Notes: May enhance liver regeneration
Outcome after laparoscopic and open resections of posterosuperior segments of the liver. BJS 2017; 104: 751-759.
Authors: V. Scuderi, L. Barkhatov, R. Montalti, F. Ratti, F. Cipriani, F. Pardo et al.
Notes: Laparoscopic equals open
Population‐based study on resection rates and survival in patients with colorectal liver metastasis in Norway. BJS 2017; 104: 580-589.
Authors: J.‐H. Angelsen, A. Horn, H. Sorbye, G. E. Eide, I. M. Løes, A. Viste et al.
Notes: Variation among patients and regions
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma. BJS 2017; 104: 600-607.
Authors: D. Ansari, M. Bauden, S. Bergström, R. Rylance, G. Marko‐Varga, R. Andersson et al.
Notes: Size matters
Randomized clinical trial
Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study). BJS 2017; 104: 525-535.
Authors: E. M. Wong‐Lun‐Hing, R. M. van Dam, G. J. P. van Breukelen, P. J. Tanis, F. Ratti, R. van Hillegersberg et al.
Notes: A lesson in trial design